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OBJECTIVES: The objectives of our study were as follows: 1) to analyze the prognostic value of macrophage
infiltration in primary IgA nephropathy (IgAN) and 2) to study the relationship between macrophages and other
factors associated with the development of renal fibrosis, including mast cells, TGF-b1, a-SMA and NF-kB.
METHODS: We analyzed 62 patients who had been diagnosed with IgAN between 1987 and 2003.
Immunohistochemical staining was performed with monoclonal antibodies against CD68 and mast cell tryptase
and polyclonal antibodies against TGF-b1, a-SMA and NF-kB p65. We also used Southwestern histochemistry for the
in situ detection of activated NF-kB.
RESULTS: The infiltration of macrophages into the tubulointerstitial compartment correlated with unfavorable
clinical and histological parameters, and a worse clinical course of IgAN was significantly associated with the
number of tubulointerstitial macrophages. Kaplan-Meier curves demonstrated that increased macrophage
infiltration was associated with decreased renal survival. Moreover, the presence of macrophages was associated
with mast cells, tubulointerstitial a-SMA expression and NF-kB activation (IH and Southwestern histochemistry). In
the multivariate analysis, the two parameters that correlated with macrophage infiltration, proteinuria and
tubulointerstitial injury, were independently associated with an unfavorable clinical course.
CONCLUSION: An increased number of macrophages in the tubulointerstitial area may serve as a predictive factor
for poor prognosis in patients with IgAN, and these cells were also associated with the expression of pro-fibrotic
factors.
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INTRODUCTION
IgA nephropathy (IgAN) is the most common type of
primary glomerulonephritis (GN) worldwide and is char-
acterized by a highly variable clinical course (1). Within 10
to 20 years of disease onset, these patients may progress to
end-stage renal disease (ESRD) (2,3), and only 3.7% of
IgAN patients develop long-standing spontaneous clinical
remission (4). As a result of these findings, many potential
prognostic factors have been extensively studied, and many
clinical and histological parameters have been implicated in
the prognosis of IgAN, including hypertension, proteinuria,
high levels of serum creatinine and injury to the tubuloin-
terstitial, glomerular and vascular compartments of the
kidney. The extent of tubulointerstitial fibrosis is believed to
better predict a decline in renal function and poor prognosis
than other known parameters (1,5), and this process has
been shown to be associated with phenotypic changes in
glomerular and interstitial cells and can be recognized by
the expression of smooth muscle actin (a-SMA) (6). A large
number of cytokines, inflammatory mediators and growth
factors produced by macrophages and other cells are related
to renal fibrosis (7,8), as macrophages orchestrate kidney
tissue repair and the replacement of specialized renal cells
following injury (9). Recently, many reports have described
two different populations of macrophages that act during
either the initiation or recovery phase of scarring (9,10). M1
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macrophages are recruited during the first 48 hours after an
acute injury, whereas M2 macrophages predominate at later
time points (11). Moreover, transcription factors such as
nuclear factor-kappa B (NF-kB) have been shown to regulate
many genes involved in the progression of renal disease
(12).
Our objectives for this study were as follows: 1) to
analyze whether the amount of macrophage infiltration in
the kidney would be associated with clinical and histolo-
gical parameters for the prediction of an unfavorable
clinical course in patients with IgAN and 2) to study the
relationship between macrophages and other factors
associated with the development of renal fibrosis, such as
mast cells, TGF-b1 (transforming growth factor beta 1), a-
SMA and NF-kB.
PATIENTS AND METHODS
Patients and Clinical Evaluation
We studied the renal biopsies of 62 patients who had been
diagnosed with primary IgAN between 1987 and 2003. The
records survey covered a four-month period during 2008,
and a review was performed in 2011. Patients with a clinical
history of alcoholism, liver diseases or Henoch-Scho¨nlein
purpura and any specimens with fewer than six identifiable
glomeruli were excluded from the study. The biopsies were
obtained from the files of the Department of Pathology at
the Medical School of Ribeira˜o Preto, Brazil. Clinical and
laboratory data were obtained from the medical records of
the patients using a previously reported protocol (13).
The following classifications of IgAN outcomes were
applied during the clinical follow-up period (13): (i) clinical
remission (CR), which was defined as proteinuria below
200 mg/day with normal renal function; (ii) clinical
improvement (CI), which was defined as regression of
nephrotic or nephritic syndrome or reduced proteinuria
with stable or improved renal function; (iii) unchanged
(UC), which was defined as unchanged clinical and
laboratory data during the course of the disease; (iv) clinical
worsening (CW), which was defined as aggravation of
nephrotic or nephritic syndrome or increased proteinuria
with normal renal function; and (v) chronic kidney disease
(CKD), which was defined as a serum creatinine level of
1.5 mg/dL or greater, a creatinine clearance of less than
90 mL/min per 1.73 m2, or the need for dialysis or renal
transplant (ESRD). We considered remission, clinical
improvement and unchanged conditions to indicate a
favorable clinical outcome, whereas clinical worsening and
CKD indicated an unfavorable clinical outcome.
Regardless of the schedule used, all patients were
assumed to have been treated for IgAN when they received
corticosteroids, regardless of whether these were adminis-
tered in combination with immunosuppressive drugs. At
the time of biopsy collection, 49 of the 62 patients had
received angiotensin-converting enzyme (ACE) inhibitor
therapy, and 6 of the 62 patients had been treated for IgAN.
Morphological Evaluation
The samples were analyzed using standard light and
immunofluorescence microscopy. The tissues obtained by
renal biopsy in the 62 IgAN patients and control sections
were stained with hematoxylin and eosin, Masson’s
trichrome and methenamine silver. Interstitial fibrosis was
assessed using the following semiquantitative scoring
system: absent, 10% of the total area; mild, 10 to 25% of
the total area; moderate, 26 to 50% of the total area; and
severe, .50% of the total area. Frozen renal tissue speci-
mens were prepared for immunofluorescence microscopy.
Immunohistochemical (IHC) Studies
These assays were performed as previously described
(13). We used the following primary antibodies: a polyclonal
antibody for NF-kB (1:200, Santa Cruz BiotechnologyH,
Santa Cruz, CA, USA); a monoclonal mouse antibody for
human macrophage CD68 (1:150, DAKO CorporationH,
Glostrup, Denmark); a monoclonal antibody for human
mast cell tryptase (1:30, NovocastraH, Newcastle Upon
Tyne, UK); a polyclonal antibody for human TGF-b1
(1:250, Santa Cruz Biotechnology, Santa Cruz, CA, USA);
and a monoclonal antibody for human a-SMA (1:1000).
Chromogenic development was performed using 3,3’ -
diaminobenzidine (DAB) (Sigma), and the samples were
counterstained with methyl green prior to dehydration and
mounting. Control kidney specimens were obtained from
normal kidney tissues of ten patients with renal cell
carcinoma who had no history of diabetes or hypertension
and no detectable histological lesions.
Quantification of mast cells and macrophages was
performed, and the number of cells/mm2 was counted
using a light microscope with a 10x magnification objective
and an automatic image analyzer (KS 300 Kontron Imaging
System, Eching bei Mu¨nchen, Germany). Extracapillary
cells, such as those present in crescents, were excluded
from the count of intraglomerular immune cells. Glomerular
expression of a-SMA and TGF-b1 was graded semi-
quantitatively as follows: (13) 0, no staining; 1, trace
mesangial staining; 2, weak segmental mesangial staining;
3, strong segmental mesangial staining; and 4, strong diffuse
mesangial staining. The a-SMA and TGF-b1 immunoreac-
tion in the tubulointerstitium and tubular NF-kB expression
in the renal cortex were scored as follows: 0, absent staining;
1, weak staining with focal distribution; 2, moderate
staining with focal distribution; 3, strong staining with focal
distribution or weak and diffuse staining; and 4, strong and
diffuse staining.
Southwestern histochemical (SWH) analysis
The non-radioactive in situ detection of NF-kB in paraffin-
embedded kidney tissue preparations was performed using
the SWH method, as previously described (14-16), with
digoxigenin labeling and detection kits (Roche Applied
Science, Indianapolis, USA). Synthetic sense DNA (Imprint
Genetics Corporation, Hialeah, USA) containing the NF-kB
sequence (59-AGTTGAGGGGACTTTCCCAGGC-39) was used
as the probe. After annealing with the complementary
sequence, the DNA probe was labeled with digoxigenin.
The sections were then incubated with the labeled probes
for 12 h at 37 C˚. Slides were then incubated with an anti-
digoxigenin antibody conjugated to alkaline phosphatase
and detected using an NBT/BCIP solution. The slides were
then mounted with glycerol. A mutant form of the probe
labeled with digoxigenin was used as a negative control.
Only morphologically recognizable cells were counted, and
the cells were considered positive when distinct, homo-
geneous, purple nuclear staining was present. NF-kB
staining by SWH was scored in the same manner as the
NF-kB staining by IHC.
Macrophages in IgA nephropathy
Silva GEB et al.
CLINICS 2012;67(7):697-703
698
Statistical Analysis
For normally distributed data, values were expressed as the
means¡ standard deviations. Proportions were tested using
the standard chi-squared test (x2) with a Yates correction or
Fisher’s exact test. Associations between continuous variables
were examined by calculating Pearson’s correlation coeffi-
cient. Simple and multivariate logistic regression models
were used to assess associations. A significant difference was
accepted if p,0.05.
Survival analyses were performed to test the association
between renal failure and the number of macrophages infil-
trating the glomerulus and tubulointerstitial area. Survival
times from the first clinical assessment to the last follow-up
visit were obtained for each patient. Univariate comparisons
of renal survival rates were made using Kaplan-Meier curves
and the log-rank test. The end-point for renal survival was
defined as ESRD requiring dialysis or transplant.
RESULTS
Sixty-two patients were included in this study, including 32
men (51.6%) and 30 women (48.4%). Twenty-four patients
were excluded from our study due to short follow-up periods
(,12 months), specimens with fewer than 6 glomeruli and
one case without hematuria. We found significant correla-
tions between an unfavorable clinical outcome of IgAN and
male gender, the absence of macroscopic hematuria, arterial
hypertension, high levels of serum creatinine, severe protei-
nuria, and elevated glomerular or tubulointerstitial injury
scores (p,0.05). For the purposes of statistical analysis, we
classified 28 (45%) patients as having a favorable clinical
course and 34 (55%) patients as having an unfavorable clinical
course. The average follow-up times were very similar
between groups, as patients with an unfavorable course
demonstrated an average follow-up time of 76.32¡47.84
months and those with a favorable course had an average
follow-up time of 73.29¡50.85 months. The clinical and
laboratory data for these two groups are shown in Table 1.
Macrophages were rarely detected in the interstitial
compartment of normal control samples, although these
cells were frequently detected in the glomerular compart-
ment. In contrast, macrophages were often detected in the
cortical interstitium and glomeruli of patients with IgAN
(Figure 1). The average number of macrophages infiltrating
the tubulointerstitial compartment was 7.14 cells/mm2 for
patients with IgAN and 3.0 cell/mm2 for the controls, and
the average number of macrophages infiltrating the glo-
merular compartment was 2.6 cells/mm2 for patients with
IgAN and 2.3 cell/mm2 for the controls.
The number of tubulointerstitial macrophages was posi-
tively correlated with the serum creatinine level at the time
of biopsy (p= 0.02; r = 0.28) and at the end of the follow-up
period (p,0.01; r = 0.46). The number of tubulointerstitial
macrophages was also correlated with the magnitude of
urinary protein excretion at the time of biopsy (p= 0.01;
r = 0.44) and at the end of the follow-up period (p,0.01;
r = 0.33). These data are shown in Figure 2.
The presence of tubulointerstitial macrophages was not
correlated with the glomerular (p= 0.50) or tubulointerstitial
(p= 0.70) expression of TGF-b1 or the glomerular expression
of a-SMA (p= 0.52). Macrophage numbers had a tendency to
correlate with NF-kB expression, as measured by SWH
(p= 0.07) and shown in Figure 3. Interestingly, the numbers
of tubulointerstitial macrophages showed positive correla-
tions with tubulointerstitial a-SMA (p= 0.01) and NF-kB
expression, as measured by IHC (p,0.01), as well as
tubulointerstitial injury (p,0.01) and poor clinical outcome
(p= 0.01). The correlation between the presence of mast cells
and macrophages infiltrating the tubulointerstitium of the
kidney was also statically significant (p,0.01).
As shown in Figure 4, we observed a significant
correlation between the infiltration of macrophages in the
tubulointerstitial compartment and the clinical disease
course (p= 0.01). Infiltrating macrophages in the tubuloin-
terstitial compartment were also correlated with the degree
of tubulointerstitial lesions (p,0.01). As shown in Figure 5, a
significant association was also detected between macro-
phages and the annual decrement of estimated glomerular
filtration rate (eGFR) during the first three years following
renal biopsy (r = 0.531, p,0.01). Because a minimum of three
years was required for the calculation of the annual
decrement of eGFR, only 47 of the 62 cases were included
in this analysis. For the other 15 patients, the follow-up
duration was between one and three years or there was
insufficient data for the eGFR calculation.
The Kaplan-Meier curve shown in Figure 6 demonstrates
the correlation between the presence of macrophages and
survival over the course of several months, whereby a
higher number of macrophages infiltrating the tubulointer-
stitium of the renal cortex predicted a lower survival rate for
renal function (p,0.05). There were no correlations between
macrophage infiltration into the glomerular compartment
and various clinical or laboratory parameters, unfavorable
clinical course or renal survival (p.0.05).
In the multivariate analysis (Table 2), the number of
macrophages was not independently associated with an
unfavorable clinical course (OR = 1.0, CI = 0.91-1.09, p= 0.93).
However, the degree of tubulointerstitial injury and the
levels of proteinuria were independently associated with
progressive disease (OR = 10.5, CI = 212-425, p= 0.01 and
OR = 7.65, CI = 1.39-42.3, p= 0.02).
Table 1 - Clinical parameters of IgAN patients with favorable vs. unfavorable clinical disease courses.
Favorable course
(n =28)
Unfavorable course
(n= 34)
Age at onset (years) 27.7¡9.2 27.2¡13.0
Gender (male - female) 10:18* 22:12
Urinary protein excretion at the time of biopsy (g/24 h) 1.9¡0.8* 2.9¡1.0
Urinary protein excretion at the end of follow-up (g/24 h) 1.1¡0.8 1.0¡0.5
Serum creatinine at the time of biopsy (mg/dL) 1.4¡0.5* 1.9¡0.4
Serum creatinine at the end of follow-up (mg/dL)
Time of follow-up (months)
2.2¡0.7*
76¡47.32
3.8¡1.3
73¡50.85
The parameters are expressed as the means¡S.D. *p,0.05.
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Figure 1 - Renal macrophage infiltration. (A) The absence of macrophages in a preserved area of the cortex, and (B) macrophages
within areas of interstitial fibrosis (A and B: objective 40x).
Figure 2 - Correlations between the number of cortical macrophages and the following variables: (A) serum creatinine (mg/dL) at the
time of biopsy (p=0.02; r = 0.28); (B) serum creatinine at the end of follow-up (p,0.01; r = 0.46); (C) protein excretion (g/24h) the time
of biopsy (p=0.01; r = 0.44); and (D) protein excretion at the end of follow-up (p,0.01; r = 0.33).
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DISCUSSION
In the present study, high levels of serum creatinine (at
the time of biopsy and at the end of the follow-up period),
severe proteinuria (at the time of biopsy and at the end of
the follow-up period), an elevated degree of tubulointer-
stitial injury and increased tubulointerstitial expression of
NF-kB and a-SMA were all significantly associated with the
number of macrophages in the tubulointerstitial compart-
ment. Furthermore, macrophage infiltration served as a
marker of the annual decrement of eGFR.
The infiltration of macrophages into the renal cortex has
been reported in patients with progressive renal disease
(17,18). In a study of 204 patients with IgAN, the presence of
macrophages (CD68-positive cells) was positively correlated
with the following: serum creatinine at the time of biopsy,
proteinuria, progression of renal disease and a worse
disease outcome (19). In addition, similar results have been
observed in pediatric patients (20). These findings are
similar to those of the present study, as we demonstrated
a correlation between macrophage infiltration and protei-
nuria and serum creatinine levels both at the time of biopsy
and at the end of the follow-up period.
Studies have shown that macrophages can synthesize
collagen I and fibronectin in vitro and can release several
fibrogenic cytokines, including TGF-b, PDGF and IL-2
(21,22). In our sample, there was no relationship between
TGF-b expression and glomerular or interstitial infiltration
by macrophages, which may have been due to the limited
sensitivity of immunohistochemistry to detect TGF-b activ-
ity in the kidney (8).
In a study of patients with chronic cyclosporine nephro-
pathy, Young et al. (23) reported that macrophage infiltra-
tion precedes the development of interstitial fibrosis.
Moreover, Geleilete et al. (24) observed an increase in
the diffuse distribution of a-SMA and ED-1 (monocytes/
macrophages) immunoreactivity in the renal cortex of
animals treated with gentamicin. In the same study, the
animals that were sacrificed 30 days after treatment demon-
strated a focal distribution of these proteins that was pre-
dominantly localized within damaged areas. Therefore, these
authors concluded that macrophages, TGF-b, endothelin
and myofibroblasts may contribute to renal injury. In our
patients, there was a correlation between the interstitial
expression of a-SMA, but not the glomerular expression of
a-SMA, and macrophage infiltration.
Figure 3 - Southwestern histochemistry for NF-kB expression. (A) The absence of staining and (B) moderate-to-intense staining in the
tubular compartment (A and B: objective 40x).
Figure 4 - A dispersion graph showing the relationship between the number of cortical macrophages and the following variables: (A)
clinical outcome (1, clinical remission; 2, clinical improvement; 3, unchanged; 4, clinical worsening; 5, chronic kidney disease; 6, end-
stage renal disease) (p=0.01) and (B) tubulointerstitial fibrosis score (0, absent; 1, mild; 2, moderate; 3, severe) (p,0.01).
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One previous study found a correlation between the
activation of NF-kB and macrophage interstitial infiltration
in patients with lupus nephritis (25). In addition, recent
studies have suggested that the NF-kB signaling pathway is
involved in the activation of macrophages (15,26). In our
study, we found a correlation between macrophage infiltra-
tion and NF-kB expression, as measured by IHC, as well as
a trending correlation between macrophage infiltration and
NF-kB expression, as measured by SWH. Although the role
of NF-kB in the activation of mast cells has been demon-
strated (27), no study has examined this relationship in renal
disease.
NF-kB participates in the regulation of gene transcription
by binding to a specific sequence of nuclear DNA known as
a response element. To better understand the operation of
this transcriptional factor, an analysis of expression at the
individual cell level is required. In our IHC analysis, NF-kB
was detected whether or not it was bound to the response
element, whereas in the SWH analysis, NF-kB was only
detected when it was unbound or weakly bound to the
response element. Because these methods provide comple-
mentary results, they can be used together to characterize
the physiological state of NF-kB (15). However, none of the
techniques described in the literature provide a fully
comprehensive description of NF-kB activation and func-
tion (28,29).
In the current study, the number of macrophages was
not independently associated with an unfavorable clinical
course, although the degree of tubulointerstitial injury was
found to be the variable most significantly associated with
poor clinical course. In addition, the multivariate analyses
identified a significant interaction between macrophage
infiltration and levels of proteinuria and tubulointerstitial
injury. In agreement with these findings, other reports have
consistently shown a relationship between interstitial
macrophage infiltration and the progression of renal fibrosis
(11,16).
Recently, several studies have suggested that there are
functionally distinct populations of macrophages that exist
within the same tissues and have opposing pro- and anti-
fibrotic actions (9,10). Despite the potential protective role of
macrophages in renal fibrosis, the number of macrophages
in the tubulointerstitial area may serve as a predictive factor
for poor prognosis in patients with IgAN, and their
presence was associated with the expression of pro-fibrotic
factors in the current study. Therefore, renal function and its
prognosis are closely correlated with the extent of tubu-
lointerstitial damage and, consequently, with the extent of
mononuclear infiltration into this compartment. However,
we observed no correlation between macrophage infiltration
into the glomerular compartment and any of the examined
clinical or histological parameters. This finding could likely
be explained by the very high percentage of patients with
non-proliferative histological forms (77.5% with focal and
segmental sclerosis and mesangiopathic forms; 6.5% with
mesangiopathic forms) in our study. In addition, the study
by Nagata et al. demonstrated that the number of macro-
phages in the glomerular compartment was significantly
higher in patients who received pathological diagnoses of
focal and diffuse proliferative glomerulonephritis than in
patients with minor glomerular abnormalities or sclerosis
(30).
However, certain limitations of our study should be
noted. First, the investigation was performed casuistically
using single-center, heterogeneous data regarding the use of
angiotensin-converting enzyme (ACE) inhibitor therapy, the
levels of renal function and immunosuppressive protocols.
In addition, the study used retrospective data collection
analysis.
In conclusion, an increased number of macrophages in the
tubulointerstitial area may serve as a predictive factor for
poor prognosis in patients with IgAN, and we found the
presence of these cells to also be associated with the
expression of pro-fibrotic factors.
Figure 5 - The correlation between the number of macrophages
in the tubulointerstitial area and annual decrement of eGFR
calculated after three years of follow-up. Figure 6 - The renal survival of patients with IgAN (n= 62) as a
function of the number of macrophages. A low score corre-
sponded to those cases with a number of cells below the median
of 7.14 cells/mm2, and a high score corresponded to those cases
with a number of cells above the median value. The end-point
for renal survival was defined as ESRD (end-stage renal disease)
requiring dialysis or transplant. The vertical hash marks on the
survival curves indicate the end of follow-up for patients who
did not develop ESRD.
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Table 2 - Risk factors for unfavorable clinical course according to the multivariate analysis.
Risk Factors Gross Logistic Regression Adjusted Logistic Regression
Odds Ratio IC 95% p-value Adjusted Odds Ratio* IC 95% Adjusted p-value*
LI LS LI LS
Macrophages 1.10 1.01 1.19 0.04 1.00 0.91 1.09 0.93
Serum Creatinine at onset 6.94 1.94 24.82 ,0.01 3.17 0.81 12.44 0.10
Proteinuria at onset (261) 4.05 1.21 13.54 0.02 7.65 1.39 42.03 0.02
Proteinuria at onset (361) 5.36 1.24 23.21 0.02 6.98 0.88 55.61 0.07
Interstitial Fibrosis (260/1) 4.07 1.17 14.15 0.03 3.52 0.67 18.53 0.14
Interstitial Fibrosis (360/1) 40.70 4.50 367.91 ,0.01 30.05 2.12 425.69 0.01
Legend: Proteinuria (1-#1 g/24 h; 2- .1 and #3.5 g/24 h; 3 .3.5); Interstitial Fibrosis (0- absent; 1- mild; 2- moderate; 3- severe); IC- confidence intervals;
LI- Lower 95% confidence limits; LS- Upper 95% confidence limits.
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